Neurocrine Biosciences (NBIX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $154.03 --0%
EPS Growth %: -12.4%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -12.4%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.07), $0.10 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- The Gap, Inc. (GAP) Tops Q2 EPS by 3c
- Karman Space & Defense acquires Walker Precision Engineering
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
